Summary
Machine-generated summaryA German health insurance entity is inviting pharmaceutical companies to sign non-exclusive drug discount agreements under § 130a (8) or 130c (1) SGB V. The contract period typically runs from August 1, 2026, to July 31, 2028. This is not a public procurement under EU Directive 2014/24/EU or the GWB, as there is no competitive selection process. The conditions, including the discount rate, are fixed and non-negotiable for all partners. Any pharmaceutical entrepreneur as defined by § 4 (18) AMG can participate. To conclude the contract, applicants must request the documents from the contact point, sign them, and submit the required declarations.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile2 open tenders right now
- Business and management consultancy - Framework agreement for pitch consultancy No deadline published
- Legal advice and representation - Framework contract for pitch consultancy No deadline published
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Status: Now marked as Closed
- Submission deadline: Moved 1 day EARLIER: now July 9, 2026, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
2
days left
€2,750,000
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,066,160
- Buyer track record on Aperlena
- 23 notices tracked · 1 awarded
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert